TILT Biotherapeutics
PrivateLast Round
Series B
May 13, 2025
Total Funding Raised
$66.6M
Company Overview
TILT Biotherapeutics is a biotechnology company developing oncolytic immunotherapies to enable T-cell therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TILT Biotherapeutics Comparables
Compare TILT Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accession Therapeutics Limited | 88% | |
| Akamis Bio | 85% | |
| ORCA Therapeutics | 85% | |
TILT Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2025 | ||||
| Grant | Feb 7, 2023 | ||||
| Series A | Feb 7, 2023 | ||||
| Series A | Jun 14, 2022 | ||||
| VC Round | Jun 16, 2020 | ||||
Seed | Dec 16, 2016 |
TILT Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B, Series A |
| Tesi | Series B, Series A |
| Business Finland | VC Round |
| Lifeline Ventures | Series B, Seed, Series A |
| EIC Accelerator | Grant |
| Tekes | Seed |
| Stephen Industries Inc Oy | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Web traffic grew 75% MoM (from 506 to 883 monthly visitors)
- Mar 4, 2026
Monthly visitors increased 61% MoM.
TILT Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TILT Biotherapeutics's valuation, stock price, and market status.